Medpace Clinical Pharmacology Unit

A partnership success story.debbie elliott

NYBA Annual Meeting, 2012 Stem Cell

Maximizing the Effectiveness of the Partnership with your CRO

MediTech a Medpace Company Two Continent Strategy

Plan Early for Late Phase Clinical Trials

Drug development in Alzheimer's Disease

Connecting the Dots for Rare Disease Studies

Pharmacovigilance Audits: Is the USA behind the curve?

Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug

Pharmacoeconomic Assessment through Market Approval and Beyond: Theory and Operations

Latin America: Challenges & Opportunities in Clinical Research

Gene Editing - Challenges and Future of CRISPR in Clinical Development

Integrating Laboratory Services

Precision Medicine: Opportunities and Challenges for Clinical Trials

Pharmacoeconomic Assessment through Market Approval and Beyond

What Happens After Your Device is Approved? Collecting Data in the Real World

Clinical Trial Supply East Asia

The CRO-Sponsor Interaction: Regulatory Affairs

Clinical Trials Conduct and Protocol Compliance in Asia